LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Ardent Health, Inc. ("Ardent†or the "Company†) (NYSE: ARDT) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ARDENT HEALTH, INC. (ARDT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? On Novembe. ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Ardent Health, Inc. ("Ardent†or the "Company†) (NYSE: ARDT) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ARDENT HEALTH, INC. (ARDT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by emai. ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - Ardent Health operates acute care hospitals and healthcare facilities, with a critical focus on the collection of accounts receivable [4]. - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections," while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health announced a $43 million decrease in revenue for the quarter and increased its professional liability reserves by $54 million due to adverse claim developments [5]. - Following this announcement, Ardent Health's stock price dropped by $4.75 per share, or over 33%, from $14.05 to $9.30 per share [5].

Core Viewpoint - The Ardent Health class action lawsuit alleges that the company and its executives made misleading statements regarding financial practices and failed to disclose critical information about accounts receivable and liability reserves, leading to significant financial losses for investors during the specified class period [1][3][4]. Group 1: Allegations and Financial Impact - The lawsuit claims that Ardent Health did not rely on accurate methods for determining the collectability of accounts receivable, which allowed the company to report inflated financial figures [3]. - A significant decrease of $43 million in third quarter 2025 revenue was revealed, attributed to revised assessments of accounts receivable collectability after a transition to a new revenue accounting system [4]. - The company cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million – $615 million to $530 million – $555 million, due to ongoing industry-wide cost pressures [4]. Group 2: Professional Liability Concerns - Ardent Health allegedly did not maintain sufficient professional malpractice liability insurance to cover potential claims, which raises concerns about its financial stability [3]. - The lawsuit indicates that the company recorded a $54 million increase in professional liability reserves due to recent settlements and ongoing litigation, reflecting broader industry trends and social inflationary pressures [4]. Group 3: Legal Process and Representation - Investors who purchased Ardent Health securities during the class period can seek appointment as lead plaintiff in the class action lawsuit, which allows them to represent the interests of all class members [5]. - Robbins Geller Rudman & Dowd LLP, the law firm handling the case, is recognized as a leading firm in securities fraud litigation, having secured over $2.5 billion for investors in 2024 alone [6].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and certain officers for alleged violations of federal securities laws during the Class Period from July 18, 2024, to November 12, 2025 [1][2]. Group 1: Allegations and Financial Impact - The lawsuit claims that Ardent Health's Q3 2025 revenue was overstated due to inadequate assessments of accounts receivable collectability following a transition to a new revenue accounting system [3]. - The company's 2025 EBITDA guidance was allegedly overstated and would be reduced by $57.5 million at the midpoint, approximately 9.6%, due to persistent industry-wide cost pressures, including payer denials [3]. - As a result, statements made by the defendants regarding the company's business, operations, and prospects were materially false and misleading [3]. Group 2: Investor Actions and Legal Representation - Investors who suffered losses in Ardent have until March 9, 2026, to request the Court to appoint them as lead plaintiff, although sharing in any recovery does not require serving as lead plaintiff [4]. - Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis, meaning they will only seek reimbursement for expenses and attorneys' fees if successful [5]. - The firm has a strong track record, having recovered hundreds of millions of dollars for investors nationwide, emphasizing their commitment to restoring investor capital and ensuring corporate accountability [6].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Ardent Health operates acute care hospitals and healthcare facilities, with a focus on the collection of accounts receivable [4]. Allegations of Misrepresentation - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method, leading to inflated accounts receivable figures [4]. Stock Price Impact - On November 12, 2025, Ardent Health announced a $43 million revenue decrease and a $54 million increase in professional liability reserves, resulting in a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the caption Postiwala v. Ardent Health, Inc., et al. [3]. Legal Representation - Bleichmar Fonti & Auld LLP, a leading law firm in securities class actions, is representing the plaintiffs, with a history of recovering significant amounts for investors [7].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for alleged violations of securities laws, specifically related to misleading statements about the company's financial practices and liabilities [1][4]. Group 1: Lawsuit Details - The lawsuit is based on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - Investors who purchased Ardent's securities between July 18, 2024, and November 12, 2025, are encouraged to participate in the lawsuit before the deadline of March 9, 2026 [2]. Group 2: Allegations Against the Company - The complaint alleges that Ardent made false and misleading statements regarding its accounts receivable and the methodology used to assess collectability [4]. - The company reportedly did not conduct detailed reviews of historical collections, instead using a 180-day cliff method to delay recognizing losses on uncollectable accounts [4]. - Additionally, Ardent failed to maintain adequate levels of professional malpractice liability insurance, contributing to the misleading nature of its public statements [4].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for misrepresentations regarding its accounts receivable during the Class Period from July 18, 2024, to November 12, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Ardent Health made false statements about its accounts receivable management, including the methods used to determine collectability and the adequacy of its professional malpractice liability insurance [5]. - Defendants allegedly misrepresented that Ardent Health employed an active monitoring process for accounts receivable, which was not the case, as they utilized a 180-day cliff for reserving accounts [5]. - The lawsuit asserts that when issues regarding increased claim denials by third-party payors arose, Ardent Health downplayed the situation and failed to write off uncollectible accounts [5]. Group 2: Investor Information - Investors who purchased Ardent Health securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm for more information [3][6]. - A lead plaintiff must be appointed by March 9, 2026, to represent the interests of other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, with over $438 million secured in 2019 alone [4].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Company Overview - Ardent Health operates acute care hospitals and other healthcare facilities, with a focus on the collection of accounts receivable [4]. Allegations of Fraud - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method that inflated reported accounts receivable and delayed loss recognition [4]. Stock Performance Impact - On November 12, 2025, Ardent Health announced a $43 million revenue decrease and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the caption Postiwala v. Ardent Health, Inc., et al. [3].

Group 1 - The article highlights that investors with significant losses in Ardent Health, Inc. have until March 9, 2026, to file lead plaintiff applications in a securities class action lawsuit [1] - The lawsuit pertains to investors who purchased or acquired Ardent's securities between July 18, 2024, and November 12, 2025 [1]